SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Infosys bags multi-million contract from AstraZeneca

16 Dec 2008 Evaluate

AstraZeneca has awarded Infosys a five year, multi-million dollar global sourcing deal. AstraZeneca, is one of the world's leading pharmaceutical companies with sales of $29.55 billion. Under the agreement, Infosys will deliver end-to-end application maintenance services to AstraZeneca’s global operations in areas such as manufacturing, supply chain, finance, human resources and other corporate functions.

 

AstraZeneca is transforming its operations through multiple phases, with the first across the United Kingdom and in the subsequent phases focusing on the United States, Europe, Latin America and Asia. In addition, as part of the transition, AstraZeneca employees in Sweden and the UK will be rebadged to Infosys, thereby strengthening its global delivery network.crackcrack

Infosys Share Price

1277.35 -15.00 (-1.16%)
13-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
TCS 2472.65
Infosys 1277.35
HCL Tech. 1429.90
Wipro 203.00
Tech Mahindra 1435.80
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×